|
Kenneth Chahine was appointed President and Chief Executive Officer and a Director of Avigen Inc. in March 2004. Dr. Chahine joined Avigen in 1998 and served first as Avigen's Vice President Business Development and Intellectual Property and then as Chief Operating Officer. Prior to joining Avigen he worked at the patent law firm of Madson & Metcalf P.C. in Salt Lake City from 1994 to 1998. Between 1992 and 1993 Dr. Chahine worked as a research scientist at Parke-Davis Pharmaceuticals and held a research scientist post at the University of Utah Department of Human Genetics from 1994 to 1996. Dr. Chahine also served as the western regional news and legal correspondent for Nature Biotechnology for many years. Dr. Chahine serves on the board of directors of the Lassonde New Venture Development Center at the University of Utah School of Business and he is an Adjunct Professor at the University of Utah College of Law. Dr. Chahine holds a J.D. from the University of Utah and a Ph.D. in biochemistry and molecular biology from the University of Michigan. | 